Few Reasons Why BioSpecifics (BSTC) Is a Great Growth Stock

[{"selector":"#anim-65971ed6-4fe6-4cb0-bd64-04ac2a27a8ed","keyframes":{"opacity":[0,1]},"delay":0,"duration":3000,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}]

Earnings Growth historical EPS growth rate for BioSpecifics is 32.5%, investors should actually focus on the projected growth. The company's EPS is expected to grow 10.3% this year, crushing the industry average, which calls for EPS growth of 5.2%

[{"selector":"#anim-8e179ec0-c4eb-4949-849f-aa65b9aeee84","keyframes":{"opacity":[0,1]},"delay":0,"duration":3000,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-5b550cfd-34a7-48fd-9e0e-72d7d71d228d","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-b6f84931-c244-4096-8744-486ef6e30e07","keyframes":{"transform":["translate3d(0px, 118.19590%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-0885ba91-b750-490c-bb86-2cbf906d158d","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-7e55acee-c974-445c-9e77-fd594b138c52","keyframes":{"transform":["translate3d(0px, 103.33031%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

Right now, year-over-year cash flow growth for BioSpecifics is 53.3%, which is higher than many of its peers. In fact, the rate compares to the industry average of 10.4%.

[{"selector":"#anim-f4141390-e0ac-4765-98a2-666665ba14a9","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-50a79c1c-265b-4a96-a7d2-16f267596315","keyframes":{"transform":["translate3d(0px, 120.77974%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-8d007865-78f9-4531-9b73-1522f1d8d841","keyframes":{"opacity":[0,1]},"delay":0,"duration":3000,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-c36ab725-5b46-43f7-9854-36ee7bdd3249","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-d8d85241-fb47-4907-b0c9-aa2f377c8dc7","keyframes":{"transform":["translate3d(0px, 150.61111%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

Promising Earnings Estimate Revisions There have been upward revisions in current-year earnings estimates for BioSpecifics. The Zacks Consensus Estimate for the current year has surged 8.3% over the past month.

[{"selector":"#anim-26895c8a-ce97-461d-82d2-d704de6a6ce5","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-6e5eba59-7ddb-47e1-a7cd-9c8e90ae7579","keyframes":{"transform":["translate3d(0px, 106.90131%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-7316f4dd-9c33-4150-894c-a68c45cc0a40","keyframes":{"opacity":[0,1]},"delay":0,"duration":3000,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-ef35adfa-b1da-49f2-bbcd-001861b11c0a","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-ba15f83e-d10b-481e-8b45-425d93150b82","keyframes":{"transform":["translate3d(0px, 121.01638%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

Bottom Line BioSpecifics has not only earned a Growth Score of B based on a number of factors, including the ones discussed above, but it also carries a Zacks Rank #1 because of the positive earnings estimate revisions.

[{"selector":"#anim-af9b25d6-f263-464d-9db5-fb876f0da80e","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-841c2070-24c1-4db9-97b7-6b0d5aefc805","keyframes":{"transform":["translate3d(0px, 106.90131%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-bb30ca7b-d5dc-4894-9bfb-d4b3aac291a8","keyframes":{"opacity":[0,1]},"delay":0,"duration":3000,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-2986544c-df4a-42eb-ba37-cf4bbf46ad7b","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-5e66c183-7eed-49e4-8047-fdcaccdaa580","keyframes":{"transform":["translate3d(0px, 121.01638%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]